Skip to content
‹ Back to IndustriesHealthcare

M&A Healthcare Advisors (MAHA) Exclusively Represents On My Care Home Health in their Sale to Excelin Health

M&A Healthcare Advisors (MAHA), a newly founded boutique merger and acquisition (M&A) advisory group, is proud to announce the sale of On My Care Home Health, a large Home Health agency providing skilled nursing, physical, occupational, and speech therapy, as well as social worker and home aide services. Located in the San Francisco Bay area,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share
M&A Healthcare Advisors (MAHA) Exclusively Represents On My Care Home Health in their Sale to Excelin Health

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

M&A Healthcare Advisors (MAHA), a newly founded boutique merger and acquisition (M&A) advisory group, is proud to announce the sale of On My Care Home Health, a large Home Health agency providing skilled nursing, physical, occupational, and speech therapy, as well as social worker and home aide services. Located in the San Francisco Bay area, On My Care was acquired by Excelin Health, a portfolio company of Corinthian Equity Fund II, L.P.

“We are excited to add On My Care to our larger portfolio and continue their tradition of excellence. Andre Ulloa and his team at M&A Healthcare Advisors went above and beyond to shepherd this transaction through closing and were integral to getting the deal done. Andre was the consummate intermediary: attentive, responsive, and consistent throughout the entire process.” – Maureen Spivack, President of MAS Advisory Services, LLC and Board Member of Excelin Health.

While the current M&A market has shown signs of slowing down in recent months, with the right support and guidance, transactions are still occurring. The M&A Healthcare Advisors team was able to create increased value for On My Care, successfully navigate through every phase of the sale process, and identify a buyer with unique synergies who would continue building upon their legacy.

“We regularly speak about how our involvement directly increases the probability of a company being sold and drives the enterprise value of the businesses we represent. The sale process for On My Care Home Health is a direct testament to those principles, our experience, and Andre’s remarkable daily effort to ensure the best outcome for our client”, say Co-Founders Mike Moran & Mark Thomas

This success proves the effectiveness of M&A Healthcare Advisors’ approach only 8 months after their founding.

“The team at M&A Healthcare Advisors [MAHA] was the perfect complement for us as a seller. They matched my work ethic and quick responsiveness. They were supportive, taking on all sale’s process tasks which did not require my involvement, allowing me to focus on my operations.

Although the tangible work product was excellent, what was most impressive to me was their technical consistency and emotional fortitude through a very arduous due diligence process. There were many evenings we would spend on the phone assessing that day’s events and adjusting our approach for the days to come. MAHA introduced me to our transactional attorneys, as well; all the while working side-by-side with the legal team to ensure that every aspect of the purchase agreement was as good as it could be.

In the end, after an eight-month process, all parties walked away with a mutually beneficial deal. I thank that, in large part, to the efforts of MAHA.” – Hans Gill, CEO of On My Care Home Health

About M&A Healthcare Advisors

M&A Healthcare Advisors (MAHA), is a boutique merger and acquisition (M&A) advisory group, focused on the lower-middle market healthcare industry. Our core purpose is to provide comprehensive, efficient, and committed transactional support for emerging or established, lower-middle market healthcare businesses. Our team is highly accessible, experienced, process-driven, and seeks to bring a superior level of guidance to every engagement. We relentlessly advocate for our clients, constantly reinforcing the most essential value: TRUST.

With over 50 successful healthcare transactions in the past five years, the team at M&A Healthcare Advisors has sold companies in a variety of healthcare segments: Behavioral Health, Autism, I/DD, Hospice, Home Health, Home Care, Private Duty, Physical Therapy, Staffing/Medical Recruiting, Not-for-Profits and all types of Pharmacy. Their full suite of services includes Sell-Side Representation, M&A Hourly Consulting, and Expert Valuation services.

Business Contact

Mark Thomas

Partner, Director of Operations

M&A Healthcare Advisors

mthomas@mahealthcareadvisors.com

Media Contact

Matt Santoro

matt@elkordyglobal.com

SOURCE M&A Healthcare Advisors

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Advocate Health's Hugh Chatham draws 65 applicants for 12 surgical tech seats

Advocate Health's Hugh Chatham draws 65 applicants for 12 surgical tech seats

Hugh Chatham Health and Alleghany Health marked one year inside Advocate Health with a surgical technology program that drew 65 applicants for 12 seats. Year one also brought $11.3 million in pay and rewards, $19.3 million in capital and nearly 1,000 specialty transfers. Local training seats look like the next limit in Elkin.

  • 01In rural North Carolina, a new surgical technology program drew more than five applicants per seat, which points to training capacity, not interest, as the thing to expand.
  • 02Pay spending in the first year of a rural affiliation came to roughly 58% of the capital figure: $11.3 million in total rewards next to $19.3 million in capital.
  • 03Transfers outnumbered virtual specialty consults about 14 to 1 in year one, so the planned growth in virtual care is the year-two number worth tracking.

Nov 10, 2026

AI cuts cardiologists' echocardiogram review time by 46%

AI cuts cardiologists' echocardiogram review time by 46%

Late-breaking research presented November 9 at the American Heart Association's Scientific Sessions 2026 reported that AI-drafted preliminary echocardiogram reports were comparable to human drafts. Cardiologists averaged 4.6 minutes finalizing AI drafts versus 8.5 minutes without AI. The findings are a non-peer-reviewed abstract.

  • 01Cardiologists averaged 4.6 minutes finalizing AI-drafted echo reports versus 8.5 minutes without AI, about 46% less time.
  • 02Cardiologists made substantial changes to 50.6% of AI drafts and 49.7% of human drafts.
  • 03The research used 1,200 echocardiograms from 21 Kaiser Permanente Northern California medical centers.

Nov 9, 2026

After Chicago: Did AI at AHA 2026 Pass Its Own Test?

After Chicago: Did AI at AHA 2026 Pass Its Own Test?

At AHA Scientific Sessions 2026 in Chicago, AI ECHO INSIGHT, WATCH-LV, PARAMOUNT and PROVAR+ showed gains in workflow efficiency, screening and treatment decisions, but none established a reduction in hard clinical events. The takeaway: the next test is proving these tools improve outcomes, especially in high-need populations, by connecting to established care.

  • 01AI ECHO INSIGHT cut echo reads 8.5 to 4.6 minutes, and PARAMOUNT changed treatment decisions, but no AI late-breaker showed fewer hard events.
  • 02ZEUS and Lp(a)HORIZON lowered their target biomarkers without reducing major cardiovascular events, a caution against treating algorithmic accuracy alone as proof of patient benefit.
  • 03Low-technology, team-based interventions such as CATCH in Colombia and Jamaica lowered blood pressure, showing the care systems AI tools must connect to.

Nov 9, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512